Boyer & Corporon Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Boyer & Corporon Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$77.31 - $88.08 $1.05 Million - $1.2 Million	-13,630 Reduced 18.09%	61,703 $5.12 Million
Q4 2022 Jan 30, 2023	SELL	$62.32 - $89.47 $29,415 - $42,229	-472 Reduced 0.62%	75,333 $6.47 Million
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $22,089 - $25,231	371 Added 0.49%	75,805 $4.68 Million
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $975,410 - $1.1 Million	16,899 Added 28.87%	75,434 $4.66 Million
Q1 2022 May 04, 2022	BUY	$57.92 - $72.58 $113,754 - $142,547	1,964 Added 3.47%	58,535 $3.48 Million
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $36,722 - $41,680	566 Added 1.01%	56,571 $4.11 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $42,847 - $46,227	633 Added 1.14%	56,005 $3.91 Million
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $3.51 Million - $3.84 Million	55,372 New	55,372 $3.81 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Boyer & Corporon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boyer & Corporon Wealth Management, LLC with notifications on news.